PhaseV vs RedC Biotech
PhaseV vs RedC Biotech, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: PhaseV is on 56/100 and RedC Biotech on 42/100.
Where each one leads
PhaseV
- our overall score: 56/100 against 42/100
- domain rating: 33/100 against 6/100
- headcount: 61 against 5
- headcount growth: +173.2% against +21.1%
- LinkedIn following: 6,602 against 1,236
RedC Biotech
- agent readiness: 48/100 against 42/100
At a glance
| Measure | PhaseV | RedC Biotech |
|---|---|---|
| What it is | Develops a platform for adaptive clinical trial design and closed-loop execution. | Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies. |
| Category | Life Sciences, Clinical Trials, Optimization, HealthTech | Life Sciences, Biotech, Blood, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2023 | 2015 |
| Headquarters | Tel Aviv, Israel | San Diego, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | PhaseV | RedC Biotech |
|---|---|---|
| Employees | 61 | 5 |
| Headcount growthLast 12 months | +173.2% | +21.1% |
| Total funding | $65.0M | Not published |
| Latest round | Series A | Not published |
| LinkedIn followers | 6,602 | 1,236 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | PhaseV | RedC Biotech |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 42/100 |
| Traction | 57/100 | 8/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 40/100 | 30/100 |
| Quality | 55/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | D (48/100) |
| Domain ratingLink authority, 0-100 | 33/100 | 6/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | PhaseV | RedC Biotech |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | Webflow | Wix |
| Analytics | Google Analytics 4 | Not detected |
PhaseV vs RedC Biotech: common questions
Which is better, PhaseV or RedC Biotech?
On our 0-100 score PhaseV rates higher (56/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do PhaseV and RedC Biotech compare on the numbers?
PhaseV leads on our overall score (56/100 against 42/100), domain rating (33/100 against 6/100), headcount (61 against 5), headcount growth (+173.2% against +21.1%), LinkedIn following (6,602 against 1,236). RedC Biotech leads on agent readiness (48/100 against 42/100).
Read the full PhaseV review and pricing or the RedC Biotech review and pricing. You can also browse other PhaseV alternatives we track.